The following data is part of a premarket notification filed by Biomerieux, Inc. with the FDA for Vitek 2 Ast-gn Tobramycin (/= 16 Ug/ml); Vitek 2 Ast-gram Negative Tobramycin (/=16 Ug/ml).
| Device ID | K163083 |
| 510k Number | K163083 |
| Device Name: | VITEK 2 AST-GN Tobramycin (/= 16 Ug/mL); VITEK 2 AST-Gram Negative Tobramycin (/=16 Ug/mL) |
| Classification | System, Test, Automated, Antimicrobial Susceptibility, Short Incubation |
| Applicant | bioMerieux, Inc. 595 Anglum Road Hazelwood, MO 63042 |
| Contact | Mary Beth Anheuser |
| Correspondent | Mary Beth Anheuser bioMerieux, Inc. 595 Anglum Road Hazelwood, MO 63042 |
| Product Code | LON |
| Subsequent Product Code | LTT |
| Subsequent Product Code | LTW |
| CFR Regulation Number | 866.1645 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2016-11-03 |
| Decision Date | 2017-02-01 |
| Summary: | summary |